MedPath

The effective of diclofenac suppository and bupivacaine on pain relief following laparoscopic herniorrhaphy surgery

Phase 2
Conditions
laparoscopic herniorrhaphy.
Unspecified abdominal hernia
Registration Number
IRCT20180522039782N2
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
60
Inclusion Criteria

The patients with ASA class one or two, who are candidate for laparoscopic herniorrhaphy

Exclusion Criteria

Allergy to the drugs studied, , , , , , and ;
History of hypertension
History of uncontrolled diabetes
History of cardiovascular diseases
History of renal failure
History of cirrhosis
History of smoking or drug abuse
pregnant women

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain relief. Timepoint: 3, 8, 12, 16, 20 and 24 hours after the intervention. Method of measurement: based on the visual analog scale (VAS).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath